1. Academic Validation
  2. Oncogenic KRAS-dependent stromal interleukin-33 directs the pancreatic microenvironment to promote tumor growth

Oncogenic KRAS-dependent stromal interleukin-33 directs the pancreatic microenvironment to promote tumor growth

  • Cancer Discov. 2024 Jul 3. doi: 10.1158/2159-8290.CD-24-0100.
Katelyn L Donahue 1 Hannah R Watkoske 2 Padma Kadiyala 3 Wenting Du 2 Kristee Brown 4 Michael K Scales 1 Ahmed M Elhossiny 3 Carlos E Espinoza 5 Emily L Lasse Opsahl 5 Brian D Griffith 6 Yukang Wen 6 Lei Sun 2 Ashley Velez-Delgado 5 Nur M Renollet 1 Jacqueline Morales 5 Nicholas M Nedzesky 6 Rachael K Baliira 3 Rosa E Menjivar 5 Paola I Medina-Cabrera 1 Arvind Rao 5 Benjamin Allen 3 Jiaqi Shi 3 Timothy L Frankel 2 Eileen S Carpenter 3 Filip Bednar 1 Yaqing Zhang 2 Marina Pasca di Magliano 3
Affiliations

Affiliations

  • 1 University of Michigan-Ann Arbor, Ann Arbor, Michigan, United States.
  • 2 University of Michigan Medical School, Ann Arbor, MI, United States.
  • 3 University of Michigan-Ann Arbor, Ann Arbor, MI, United States.
  • 4 University of Michigan Medical Schooligan, United States.
  • 5 University of Michigan-Ann Arbor, Ann Arbor, United States.
  • 6 University of Michigan-Ann Arbor, United States.
Abstract

Pancreatic Cancer is characterized by an extensive fibroinflammatory microenvironment. During carcinogenesis, normal stromal cells are converted to cytokine-high Cancer associated fibroblasts (CAFs). The mechanisms underlying this conversion, including regulation and function of fibroblast-derived cytokines, are poorly understood. Thus, efforts to target CAFs therapeutically have so far failed. Here, we show that signals from epithelial cells expressing oncogenic KRAS -a hallmark pancreatic Cancer mutation- activate fibroblast autocrine signaling, which drives expression of the cytokine interleukin-33 (IL-33). Stromal IL-33 expression remains high and dependent on epithelial KRAS throughout carcinogenesis; in turn, environmental stress induces IL-33 secretion. Using compartment-specific IL-33 knockout mice, we observed that lack of stromal IL-33 leads to profound reprogramming of multiple components of the pancreatic tumor microenvironment, including CAFs, myeloid cells and lymphocytes. Notably, loss of stromal IL-33 leads to an increase in CD8+ T cell infiltration and activation, and, ultimately, reduced tumor growth.

Figures
Products